ArticleJournal of translational medicine2024

IFI16 promotes the progression of clear cell renal cell carcinoma through the IL6/PI3K/AKT axis.

Ke Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.